
Opinion|Videos|September 3, 2025
Empowering Pharmacists in the Management of Patients With Urothelial Cancer
Listen
0:00 / 0:00
Sherry Vogt, PharmD, BCOP; and Megan Hinkley, PharmD, MBA, BCOP, discuss how pharmacists play a crucial role in managing patients with bladder cancer through treatment selection, patient education, adverse effect monitoring, and the evolving landscape of therapies including traditional chemotherapy, immunotherapy, and antibody-drug conjugates like enfortumab vedotin plus pembrolizumab.
Advertisement
0:13 Urothelial Cancer Background
9:08 Patient Education
15:45 Chemotherapy Toxicities
21:17 Unmet Needs
29:14 Antibody-Drug Conjugates
36:55 Adverse Event Management
42:30 Other Considerations
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Approves Ensitrelvir for Post-Exposure Prophylaxis of COVID-19 in Adolescents and Adults
2
What Pharmacists Need to Know About Retatrutide's TRIUMPH-1 Phase 3 Results
3
Why Some Patients Do Not Respond to GLP-1 Therapies
4
GIRE Combination Shows PFS Benefit in First-Line Metastatic Breast Cancer Treatment, Earning FDA Priority Review
5





































































































































